ТОО "ЕМ КЛИНИКА"
This is a company preview
Unlock the full report for 1 check — contacts, bank accounts, court cases, government contracts, arrests, licenses and PDF export.
Risks
0/18Комитет государственных доходов · Государственные закупки РК · АО ФНБ «Самрук-Казына» · АОО «НИШ»This assessment is informational and analytical only, based on our internal methodology and open sources; it is not an official government conclusion or a guarantee of reliability.
Procurement signals
Court cases
Arrests & encumbrances
Enforcement proceedings
Certificates
Licenses and permits
Summary
Министерство юстиции РКActivities
1ОКЭДСтоматологическая деятельность
Contacts
Change history
Tax payments
6By year · ₸
| Indicator | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Tax paid | 43.3K | 0 | 0 | 0 | 0 | 0 |
| Penalty | 0 | 0 | 0 | 0 | 0 | 0 |
| Fine | 0 | 0 | 0 | 0 | 0 | 0 |
| VAT refund | 0 | 0 | 0 | 0 | 0 | 0 |
Financial statements
PremiumPublic contracts
What it sells and where
Samruk-Kazyna procurement
Tender bids
Procurement as a customer
Assets
Bank accounts
Leadership
1- МЕ
Мусагалиев Ержан Бакитжанович
Director
Founders
Accreditations
Employees
Affiliated companies
PremiumDirector's involvement in other legal entities
Branches
Company networks
PremiumSimilar companies
Media mentions
Company summary
ТОО "ЕМ КЛИНИКА" (BIN 260540017034): Active legal entity, Almaty, registered in 2026. The main line of business is healthcare. Enterprise category: small enterprise, 16 to 20 employees. No risk indicators for «ЕМ КЛИНИКА» were found in open registries. Director on record: Мусагалиев Ержан Бакитжанович. Registry data current as of June 11, 2026.
Data sources and disclaimer
Sources: Министерство юстиции РК, Комитет государственных доходов МФ РК, Верховный Суд РК, Портал государственных закупок РК, АО «Самрук-Казына», Бюро национальной статистики РК, Портал электронного лицензирования. Data is collected automatically and may lag behind primary sources; the absence of a record does not guarantee the absence of the fact. This is reference information and does not replace an official extract. Methodology: SafeDeal editorial policy.